Ayr Wellness Inc. - Rights | CSE - Canadian Securities Exchange

Ayr Wellness Inc. - Rights

Listing Exchange:

CSE

Status:

Active

Industry:

Life Sciences

Symbol:

AYR.RT

CSE Index:

Currency:

Each Right entitles the holder to receive, for no additional consideration, one-tenth of one Subordinate Voting Share, subject to certain adjustments. Any Right that has not been converted by 5:00 p.m. on May 24, 2021 shall be null and void. The Rights expired on May 24, 2021.

Ayr Strategies Inc. - Subordinate Voting Shares

Ayr Wellness Inc. - Rights (AYR.RT)

SEDAR Information

Company Info

Address

590 Madison Avenue, 26th Floor

New York, NY 10022

United States

Phone

949-574-3860

Fax

212-299-7666

AYR@gatewayir.com

Listing date

Monday, August 19, 2019

Transfer Agent

Odyssey Trust Company

Capitalization

Issued & Outstanding:

1,506,788

Reserved for Issuance:

News Releases

19/11/2020

Ayr Strategies Completes Acquisition of DocHouse in Pennsylvania - Press Release November 19 2020

18/11/2020

Ayr Strategies Reports Third Quarter 2020 Results & Updates Investors on 2021 Expansion Initiatives - Press Release dated November 18, 2020

Bulletins

19/05/2021

2021-0524 - Expiry - Ayr Wellness Inc. - Rights (AYR.RT)

Le 19 mai/May 2021

Ayr Wellness Inc. rights listed on August 19, 2019 will expire on May 24, 2021.

Further to Section 1.7 of the rights indenture, "If any day on or before which any action or notice is required to be taken or given hereunder is not a Business Day, then such action or notice shall be required to be taken or given on or before the requisite time on the next succeeding day that is a Business Day."

The rights will therefore expire on May 25, 2021.

CSE Filings

File	Type	Date
Q3 2020 MD&A	MD&A (Management Discussion and Analysis)	18/11/2020
Q3 2020 Interim Financial Statements	Interim Financial Statements	18/11/2020
Form 6 - Certificate of Compliance - October 2020	Certificate of compliance	04/11/2020
Form 7 - Monthly Progress Report October 2020	Monthly Progress Report	04/11/2020
reviewed Interim Financial Statements for the Q2 period ended June 30, 2020	Interim Financial Statements	08/10/2020
Form 7 - Monthly Progress Report September 2020	Monthly Progress Report	06/10/2020
Form 6 - Certificate of Compliance August 2020	Certificate of compliance	03/09/2020
Form 7 - Monthly Progress Report August 2020	Monthly Progress Report	03/09/2020
Q2 Interim MD&A for the period ended June 30, 2020	MD&A (Management Discussion and Analysis)	26/08/2020